Molecular diagnostics

We use a multitude of expression systems including our bacterial, yeast and baculovirus expression systems that can help you develop enzymes for IVD, mRNA vaccines, and scientific research.

Our platform is capable of recombinantly expressing 100 clones in a single batch, enabling efficient screening of top-performing enzymes.

Our processes ensure the robust production of enzymes with high purity and increased yields.

Our customized preservation and reaction buffers are formulated to pharmaceutical standards to ensure the stability and specificity of enzymes.

We functionally modify enzymes using adaptors, antibodies, nanobodies, and functional groups in organic chemistry.

All our large capacity reactors, among over 100 imported bioreactors, are single-use, eliminating the risk of cross-contamination. Our single batch production capacity of up to 2,000 L is industry-leading, with high production stability and consistent process control. We are fully equipped to meet your large-scale production requirements.

We have multiple automated medium and large ӒKTA pure™ chromatography systems, with per batch production capacity ranging from 200 million to 1 billion units. Our industry leading production capacity caters to the varied demands from laboratories to industrial scale users.

Our raw material performance is constantly evaluated using multiple technology platforms to ensure they meet the market and batch-to-batch requirements.